6-sialyllactose ameliorates dihydrotestosterone-induced benign prostatic hyperplasia through suppressing VEGF-mediated angiogenesis - Kim, Eun-Yeong; Jin, Bo-Ram; Chung, Tae-Wook; Bae, Sung-Jin; Park, Hyerin; Ryu, Dongryeol; Jin, Ling; An, Hyo-Jin; Ha, Ki-Tae (BMB reports, 2019)
Keywords: 6-Siallylactose; Animals; Benign prostatic hyperplasia; Computational Biology; Culture Media, Conditioned; Dihydrotestosterone; Dihydrotestosterone - toxicity; Human Umbilical Vein Endothelial Cells; Humans; Lactose - analogs & derivatives; Lactose - therapeutic use; Male; Neovascularization, Pathologic - chemically induced; Neovascularization, Pathologic - drug therapy; Prostatic Hyperplasia - chemically induced; Prostatic Hyperplasia - drug therapy; Rats; Sialic Acids - therapeutic use; Vascular Endothelial Growth Factor A - metabolism; VEGF; VEGFR-2; 화학; Benign prostatic hyperplasia; Dihydrotestosterone; 6-Siallylactose; VEGF; VEGFR-2